Since 2001, Management Today has scoured the UK in search of the country’s most promising young business women, celebrating entrepreneurs, designers, lawyers, bankers and corporate high-flyers. Published annually, the list has previously featured the renowned names, including Martha Lane Fox, Elisabeth Murdoch and Stella McCartney.
Fiona was recognised by Management Today for her success in guiding clients in the Biotechnology and Pharmaceutical industries through multiple fund-raising rounds and partnering successes, helping them raise well in excess of £200 million in investment the last three years alone.
Fiona Stevens, Partner at GJE said: “To be included and recognised alongside such an inspiring group of women is an incredible honour. I’m delighted to be included in the 2017 list and extremely grateful for the professional opportunities I’ve been presented with since joining the firm in 2005.”
Peter Finnie, Managing Partner at GJE, said: “Fiona excels at elements of the job that come easily to very few patent attorneys, namely the ability to win and develop new client work through a combination of professional and technical excellence, and strong interpersonal skills. Clients like her and enjoy working with her, often referring new clients to her on the basis that they too will enjoy working with her. Her ability to reveal and understand clients’ needs means she is able to provide a tailored, commercially-focused, legal service, which expands the advice she delivers across a much broader range of business issues than is traditionally expected of patent attorneys.
“In an industry that has long been regarded as a male-dominated field, Fiona’s success should inspire younger female attorneys looking to find an example of the qualities and behaviours expected of future Partners.”
Fiona joined GJE in 2005 and became a partner in 2015, joining GJE’s 11 other UK partners. In her career as a patent attorney, Fiona has drafted and prosecuted applications relating to gene therapy, drug re-profiling, medical devices, novel therapeutic compounds, polymer chemistry and fuel cells.